ProShare Advisors’s Centessa Pharmaceuticals CNTA Stock Holding History

ProShare Advisors’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,351	Closed	-$213K	–	1936
2026 Q1	$213K	Buy	+5,351	New	+$137K	﹤0.01%	1537

ProShare Advisors's CNTA Position: Q2 2026 in Review

ProShare Advisors sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 5,351 shares — an estimated $213K sold.

ProShare Advisors first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $213K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

ProShare Advisors reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
ProShare Advisors sold 5,351 Centessa Pharmaceuticals shares in Q2 2026, an estimated $213K.
ProShare Advisors first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
ProShare Advisors's Centessa Pharmaceuticals position peaked at $213K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.